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Abstract
Background and aims
Neuromedin U (NMU) is a hypothalamic neuropeptide with important roles in several meta-
bolic processes, recently suggested as potential therapeutic target for obesity. We analysed
the associations between NMU gene variants and haplotypes and body mass index (BMI) in
a large sample of European children.
Methods and results
From a large European multi-center study on childhood obesity, 4,528 children (2.0–9.9
years, mean age 6.0±1.8 SD; boys 52.2%) were randomly selected, stratifying by age, sex
and country, and genotyped for tag single nucleotide polymorphisms (SNPs; rs6827359,
T:C; rs12500837, T:C; rs9999653,C:T) of NMU gene, then haplotypes were inferred.
Regression models were applied to estimate the associations between SNPs or haplotypes
and BMI as well as other anthropometric measures. BMI was associated with all NMU SNPs
(p<0.05). Among five haplotypes inferred, the haplotype carrying the minor alleles (CCT, fre-
quency = 22.3%) was the only associated with lower BMI values (beta = -0.16, 95%CI:-
0.28,-0.04, p = 0.006; z-score, beta = -0.08, 95%CI:-0.14,-0.01, p = 0.019) and decreased
risk of overweight/obesity (OR = 0.81, 95%CI:0.68,0.97, p = 0.020) when compared to the
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most prevalent haplotype (codominant model). Similar significant associations were also
observed using the same variables collected after two years’ time (BMI, beta = -0.25, 95%
CI:-0.41,-0.08, p = 0.004; z-score, beta = -0.10, 95%CI:-0.18,-0.03, p = 0.009; overweight/
obesity OR = 0.81, 95%CI:0.66,0.99, p = 0.036). The association was age-dependent in
girls (interaction between CCT haplotypes and age, p = 0.008), more evident between 7 and
9 years of age. The CCT haplotype was consistently associated with lower levels of fat
mass, skinfold thickness, hip and arm circumferences both at T0 and at T1, after adjustment
for multiple testing (FDR-adjusted p<0.05).
Conclusions
This study shows an association between a NMU haplotype and anthropometric indices,
mainly linked to fat mass, which appears to be age- and sex-specific in children. Genetic var-
iations within or in linkage with this haplotype should be investigated to identify functional
variants responsible for the observed phenotypic variation.
Introduction
Neuromedin U (NMU) is a neuropeptide mainly expressed in brain, adipose tissue and gastro-
enteric tract. NMU plays important roles in appetite regulation, energy homeostasis, gastric
secretion, smooth muscle contraction and bone remodeling, as well as in progression of differ-
ent types of cancer. This neuropeptide might therefore be a novel target for the treatment of
many diseases, and some analogs have already been developed for treatment of obesity and
metabolic disturbances [1].
Some evidence suggests a strong impact of NMU on the regulation of eating behavior and
adiposity. Transgenic mice models showed that Nmu-null mice are hyperphagic and have a
decreased energy expenditure, resulting in increased adiposity, decreased insulin sensitivity
and increased bone mass [2,3]. Experimental studies showed that intracerebroventricular
administration of NMU decreases food intake and feeding-associated behavior in rats, leading
to food intake reduction and loss of body weight, as well as increased locomotor activity and
increased heat production [4–7]. At the same time, peripheral administration of NMU lead to
reduced NMU concentrations in the hypothalamus [8]. All these findings suggest that NMU
acts through both central and peripheral mechanisms. However, the specific mechanisms of
action still remain to be elucidated.
Although many studies using animal models are available, there are few studies on the role
of NMU in humans. A genome-wide linkage study in Europeans found suggestive genetic
linkage of obesity to the region containing NMU on chromosome 4 [9]. Furthermore, in a can-
didate gene study, Hainerovà et al. [10] showed an association between a missense polymor-
phism of NMU gene and adiposity parameters in a Danish adult population and suggested a
linkage with childhood obesity. No genome-wide association studies (GWAs) on obesity iden-
tified signals for single nucleotide polymorphisms (SNPs) near the NMU region. However,
GWAs do not have sufficient resolution to capture all genetic variations and, although the her-
itability of body mass index (BMI) is 40–70%, the SNPs identified associated in GWAs
explained only 2.7% of the total variance [11]. An alternative way to study the association
between genetic variations and phenotypes is haplotype analysis. This approach allows to cap-
ture most of the existing combinations of genetic variants found in a population (haplotypes),
NMU haplotypes and adiposity in children
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confined to specific regions delimited by historical recombination events (haplotype blocks).
Functional genetic variants in haplotypes of small haplotype blocks, which have a low proba-
bility to be captured by spread markers used in GWAs, could reasonably be responsible for the
‘missing heritability’ [12]. The DNA sequence of NMU and its haplotype blocks are short, as
well as highly conserved across different species. For this reason, a high impact on peptide
function is expected for human genetic variations. Following the haplotype approach, we have
recently identified an association between variations in a NMU haplotype block and bone stiff-
ness in a children population [13].
In the present study we investigated the associations between variations in this NMU haplo-
type block and BMI in a large sample of European children of the IDEFICS (Identification and
prevention of Dietary- and lifestyle-induced health EFfects In Children and infantS) study
[14]. Because the NMU gene expression changes from infancy to puberty [15], we investigated
whether also the potential associations change during child growth due to interactions
between genetic and age-specific factors. Furthermore, to identify the mechanisms through
which NMU regulates adiposity, we also considered the potential association with several fat
and fat-free mass related indices in addition to BMI.
Material and methods
Study population
IDEFICS is a large European multi-center study on childhood obesity [14]. A cohort of 16,224
children aged 2.0–9.9 years was recruited in a population-based survey between September
2007 and May 2008 (T0), in eight European countries (Belgium, Cyprus, Estonia, Germany,
Hungary, Italy, Spain and Sweden). A community oriented intervention program for primary
prevention of obesity was implemented, using an integrated set of actions at different levels of
society to facilitate the adoption of a healthy lifestyle [16]. Children were allocated to either
control or intervention group and were followed up for two years (T1, 2009–2010). Ethical
approval was obtained by the ethical committees belonging to each of the eight centers
engaged in the fieldwork: Ethics Committee, University Hospital, Gent, Belgium; Cyprus
National Bioethics Committee, Strovolos, Cyprus; Tallinn Medical Research Ethics Commit-
tee, Tallinn, Estonia; Ethics Committee, University of Bremen, Bremen, Germany; Ege´szse´gu¨-
gyi Tudoma´nyos Tana´cs, Pe´cs, Hungary; Comitato Etico, ASL Avellino, Avellino, Italy;
Comite´ E´tico de Investigacio´n, Clı´nica de Arago´n (CEICA), Zaragoza, Spain; Regional Ethics
Committee, University of Gothenburg, Gothenburg, Sweden. Both children and their parents
gave oral (children) and written (parents) informed consent.
For this analysis, a subgroup of 4,678 samples was randomly selected from the total study
population of European descent children, stratifying by age, sex and country (about 600 sub-
jects from each country) [13,17,18].
Data collection
Data were collected at baseline (T0) and after two years (T1). Height and weight were mea-
sured using a standard clinical Seca 225 stadiometer (Seca, Hamburg, Germany) to the nearest
0.1 cm and a scale (BC 420 SMA; Tanita, Amsterdam, The Netherlands) to the nearest 0.1 kg,
respectively. Children wore underwear clothes, without shoes. The Tanita scale also measured
leg-to-leg impedance. BMI was calculated as weight(kg)/height(m)2. For the definition of over-
weight/obesity, children were grouped into categories using the BMI cut-points defined by
Cole et al. [19]. Fat-free mass (FFM) was calculated using the Tyrrell et al. [20] formula: FFM
(kg) = 0.31×height(cm)2/impedance(cm/O)+0.17×height(cm)+0.11×weight(kg)+0.942×S-
14.96, where S = 1 for girls and 2 for boys. Waist and hip circumference was measured with an
NMU haplotypes and adiposity in children
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inelastic tape (Seca 200), precision 0.1 cm, range 0–150 cm, with the subject in a standing posi-
tion. Tricipital and subscapular skinfold thickness was measured with a Holtain caliper (Hol-
tain, Holtain Ltd, Pembrokeshire, UK, range 0±40 mm). Measures were taken twice on the
right hand side of the body and the mean was used in subsequent analyses. All measurements
were collected by standardized protocols across centers and intra- and inter-observer reliabil-
ity was carefully checked [21].
Genotyping
DNA was extracted from saliva samples (Oragene DNA Self-Collection Kit, OG-300/OG-250;
DNA Genotek Inc., Kanata, Ontario, Canada) [22]. Three tag SNPs (rs6827359, rs12500837,
rs9999653; intronic regions) of the central haplotype block among the three main blocks of the
NMU gene (chr4, 55595229–55636698, GRCh38.p7 assembly; S1 Fig) were selected from the
Caucasian HapMap Project data using the Tagger Pairwise method of Haploview software
(version 4.1; Broad Institute, Cambridge, MA, USA) [23]. Tag SNP selection criteria were: (i) a
pairwise r2 threshold of 0.8 (S1 Table); (ii) SNPs defining haplotypes with frequency >10%.
The selected tag SNPs cover only 33% of genetic variance of the whole haplotype block, how-
ever they discriminate all the four main haplotypes found in Caucasian population (S1 Fig
panel c). The analysis based on the selected haplotype frequency and sample size is able (80%
power, α = 0.05) to detect a true difference of ±0.1 in BMI (as expected from previous associa-
tion studies) with a glm regression using posterior probabilities of pairs of haplotypes in a
codominant model. The SNPs were genotyped by a multiplexed end-point assay. The allelic
discrimination was performed by 7500 Fast Real-Time System (Applied Biosystems). The gen-
otyping success rate was on average 97.6% and a randomly selected sample (5%) was newly
genotyped for all SNPs, with 100% concordance.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was assessed with the chi-square test. Distribution of
continuous variables was assessed using the Kolmogorov–Smirnov test and z-scores or log-
transformed variables were used where appropriate (BMI, weight, skinfolds and waist, hip and
arm circumferences). The best genetic model was checked for each genotype–phenotype asso-
ciation, testing dominance deviation from additivity and considering the additive model as
default [18].
Ordinary least square regression was applied to estimate the associations between BMI or
BMI z-scores and gene variants with SAS software (v9.3,SAS Institute Inc., Cary, NC). The
Haplo.stats package of R software (v3.2.1; https://www.R-project.org/), was used to estimate
the haplotype frequencies and to verify the associations between haplotype and phenotype
(haplo.glm function, the most prevalent haplotype as reference). Haplotypes with frequencies
lower than 1% were excluded. Logistic regression was used to estimate the association between
gene variants and BMI categories. The analyses were performed using data collected at T0,
then the analysis was repeated for data newly collected at T1, to cross-sectionally replicate the
haplotype-phenotype associations observed at T0. To evaluate if the associations were depen-
dent on age, the interaction between haplotypes and age was also tested, adding their interac-
tion term (haplotypeage as continuous) to the full regression models. The BMI values and z-
scores were plotted in a graph to show changes over time, through a locally weighted regres-
sion (PROC SGPLOT with LOESS statement in SAS) using a scatterplot smoothing method
that automatically determines the optimal smoothing parameter [24]. Age, sex, country and
(for T1) intervention (yes/no) were considered as covariates.
NMU haplotypes and adiposity in children
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Regression analyses were performed to evaluate associations between genotypes/haplotypes
and all anthropometric indices. Since several secondary associations were tested, the Benja-
mini-Hochberg false discovery rate (FDR) [25] was used to adjust the results for multiple com-
parisons, using PROC MULTTEST in SAS. A FDR-adjusted p value (pFDR)<0.05 was
considered as statistically significant.
Results
Population characteristics
Characteristics of the study population are listed in Table 1. Children with at least one SNP
successfully genotyped in the NMU gene were 4,528 (T0 sample). Among them, 3,277 (72.4%;
intervention group: N = 1598, 48.8% of the T1 sample) returned for follow-up at T1. At T0
(mean age 6.0±1.8 SD, boys 52.2%), the mean BMI was 16.35(±2.33 SD; BMI z-score 0.18±1.29
SD), while at T1 (mean age 8.0±1.8 SD, boys 52.0%) was 17.06 (±2.95; BMI z-score 0.34±1.31
SD). All genotypes were in HWE and the minor allele frequencies (MAF) were similar to val-
ues reported in the HapMap database for Caucasians (Table 2). Five haplotypes were inferred
(Table 3; wild-type haplotype 43.9%).
Association with BMI
The additive model was the best genetic model for all genotype- and haplotype-phenotype
associations. BMI was associated with all NMU SNPs (Table 4). Among haplotypes, CCT (hap-
lotype frequency 22.3%; heterozygotes 34.8%, homozygotes 5.0%) showed significant negative
associations with BMI (β = -0.16 for each haplotype copy, 95%CI:-0.28,-0.04, p = 0.006; z-
scores -0.08, 95%CI:-0.14,-0.01, p = 0.019), as compared to the wild type (TTC, 43.9%), while
the other haplotypes did not (S2 Table). Analysis at T1 showed similar results (-0.25; 95%CI:-
Table 1. Anthropometric characteristics of N = 4,528 children with genotype data recruited at baseline of the IDEFICS study.
T0 T1
T0 All F (47.8%) M (52.2%) T1 All F (48.0%) M (52.0%)
N Mean±SD Mean±SD Mean±SD N Mean±SD Mean±SD Mean±SD
Age (years) 4,528 6.02±1.80 6.04±1.79 6.01±1.81 3,277 8.03±1.78 8.06±1.77 8.01±1.79
Body Mass Index (Kg/m2) 4,528 16.35±2.33 16.34±2.35 16.36±2.31 3,277 17.05±2.95 17.05±2.91 17.07±2.98
BMI z-score 4,528 0.18±1.29 0.17±1.32 0.20±1.27 3,277 0.34±1.31 0.33±1.32 0.34±1.30
Weight (kg) 4,528 22.96±6.89 22.73±6.88 23.18±6.88 3,277 29.40±9.02 29.18±9.00 29.61±9.04
Fat mass (kg) 4,463 7.21±3.23 7.86±3.24 6.63±3.11 3,227 9.10±4.98 9.83±4.88 8.42±4.98
Fat free mass (kg) 4,454 15.77±4.70 14.87±4.57 16.62±4.71 3,227 20.27±5.08 19.31±4.91 21.17±5.08
Triceps+subscapular skinfolds (cm) 4,391 18.23±7.33 19.56±7.63 17.02±6.81 3,180 20.66±9.75 22.19±9.76 19.24±9.52
Triceps skinfold (mm) 4,416 11.16±3.94 11.98±4.04 10.41±3.68 3,184 12.41±5.03 13.30±4.97 11.60±4.95
Subscapular skinfold (mm) 4,413 7.09±3.81 7.60±4.08 6.61±3.49 3,183 8.25±5.16 8.91±5.29 7.65±4.96
Waist circumference (cm) 4,527 54.24±6.77 53.92±6.76 54.52±6.76 3,222 58.45±8.15 58.04±8.09 58.85±8.20
Hip circumference (cm) 4,527 62.77±7.90 63.02±7.90 62.54±7.90 3,205 68.67±8.84 69.05±8.85 68.32±8.83
Waist/hip ratio 4,526 0.87±0.05 0.86±0.06 0.87±0.05 3,200 0.85±0.05 0.84±0.05 0.86±0.05
Mid-upper arm circumference (cm) 4,497 18.77±2.45 18.87±2.46 18.68±2.43 3,016 20.26±3.10 20.36±3.09 20.16±3.10
BMI categories N % N(%) N(%) N % N(%) N(%)
Thinness 478 10.6% 208(9.6%) 270(11.4%) 324 9.9% 151(9.6%) 173(10.2%)
Normal weight 3,234 71.4 1,527(70.6%) 1,707(72.2%) 2,256 68.8% 1,081(68.7%) 1,175(69.0%)
Overweight 541 11.9% 292(13.5%) 249(10.5%) 496 15.2% 242(15.4%) 254(14.9%)
Obese 275 6.1% 137(6.3%) 138(5.8%) 201 6.1% 99(6.3%) 102(6.0%)
doi:10.1371/journal.pone.0172698.t001
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0.41,-0.08, p = 0.004; z-scores -0.10, 95%CI:-0.18,-0.03, p = 0.009; Table 4). Logistic regression
analyses showed significant decreased risk of being overweight or obese in the presence of vari-
ant alleles in two of the three SNPs and the CCT haplotype (OR = 0.81; 95%CI:0.68,0.97;
p = 0.020), confirmed at T1 (Table 4). The analyses were repeated using the haplotype carrying
the ancestral alleles as reference (TTT, haplotype frequency 7.2%), obtaining similar results (S2
Table). Results of association analyses using dominant and recessive models are also reported
in S2 Table.
A significant interaction between the CCT haplotype and sex was observed only at T1 (BMI
p = 0.02); after stratification by sex, an interaction between CCT and age was significant only
in girls (p = 0.008). Fig 1 shows the BMI age trend by CCT haplotype status in boys and girls.
In girls, a difference between curves appeared to start after 7 years and became evident
between 7 and 9 years.
Association with other anthropometric parameters
The association between anthropometric indices and genotypes were consistent with the
observed associations with BMI (Table 4). Haplotype analysis confirmed CCT as the only one
significantly associated with lower anthropometric values, with similar associations at T0 and
T1 (Table 4 and S2 Table).
Children’s weight was lower by 0.31 (95%CI:-0.55,-0.08; pFDR = 0.028) and 0.59 (-0.99,-
0.19; pFDR = 0.020) kilograms at T0 and T1, respectively, for each haplotype copy. This effect
was driven by fat mass, while fat-free mass reduction was not significant. Skinfolds and hip
circumference were also significantly decreased at both T0 and T1 (Table 4). Conversely,
waist circumference was significantly decreased only in FDR-unadjusted analysis, while its
derived measures, such as waist-to-height and waist-to-hip ratios, were not significantly
modified.
Table 2. Allele frequencies and Hardy-Weinberg equilibrium of the NMU SNPs (n = 4,528 with at least one SNP successfully genotyped; T0).
SNP N Major:minor allele Homozygous (major allele) Heterozygous _ Homozygous (minor allele) HWE (p) MAF (%) CEU (%)
rs6827359 4508 T*:C 1211 (26.9%) 2199 (48.8%) 1098 (24.3%) 0.11 49 40
rs12500837 4505 T*:C 2580 (57.3%) 1656 (36.7%) 269 (6.0%) 0.91 24 21
rs9999653 4506 C:T* 967 (21.5%) 2212 (49.1%) 1327 (29.4%) 0.42 54 49
HWE: Hardy-Weinberg equilibrium, p value; MAF: Minor Allele Frequency in the sample; CEU: MAF in CEPH population (Utah residents with Northern and
Western European Ancestry) from International HapMap Project.
* Ancestral allele
doi:10.1371/journal.pone.0172698.t002
Table 3. Haplotype frequencies in the whole sample and stratified for BMI categories (n = 4,528 with at least one SNP successfully genotyped; T0).
Alleles Haplotype frequencies
rs6827359 rs12500837 rs9999653 Whole sample Thinness Normal weight Overweight Obese
T T C 43.9% 44.6% 43.3% 46.8% 46.0%
C T T 24.4% 22.9% 24.4% 24.5% 24.0%
C C T 22.3% 23.3% 22.7% 20.0% 22.2%
T T T 7.2% 7.3% 7.4% 7.1% 5.7%
C C C 2.0% 1.8% 2.2% 1.5% 2.2%
Rare haplotypes with frequency lower than 1% were not considered (CTC, TCC, TCT, accounting for less than 0.2%)
doi:10.1371/journal.pone.0172698.t003
NMU haplotypes and adiposity in children
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Discussion
Our study shows an association between NMU polymorphisms and adiposity related indices
in a large population of European children, using a haplotype-based approach. The main result
is the identification of a haplotype strongly associated with BMI, in a small haplotype block of
the NMU gene. Moreover, we observed a sex specific effect and an age-dependent association
in girls. Finally, we identified the anthropometric parameters which appear to drive the
increase in BMI, with a stronger association with fat mass, and a minor association with mea-
sures of fat free mass.
Although considerable data from animal models are available, suggesting multiple func-
tions for NMU, very few studies on humans have been performed [10,13]. Hainerovà et al. [10]
identified an association between the rare homozygotes status in a missense variant of NMU
gene and the adult overweight-obesity risk, with males showing increased waist and hip cir-
cumferences. In our study, we identified a single haplotype strongly associated with BMI and
several anthropometric indices. We observed a concordant reduction in all these parameters,
biologically concordant also with the reduction in bone stiffness previously observed in the
same sample [13]. Our result showed in a large population that children carrying particular
Fig 1. BMI (crude values and z-scores) age trend with 95% confidence intervals by haplotypes (CCT/x, red, vs
carriers of the most prevalent haplotype, TTC, blue) in boys and girls. The graphs were drawn pooling T0 (2–10
years) and T1 (4–12 years) data to have a single comprehensive view. All children contributed with their measures
weighted by haplotype posterior probabilities. Each BMI value of children contributing with both T0 and T1 measures was
also weighted 0.5, to take into account the effect of repeated observations in the same subject. Local regression method
implies that statistical power decreases at extreme x values (larger confidence intervals).
doi:10.1371/journal.pone.0172698.g001
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NMU genetic variants have lower adiposity indices and a lower risk of overweight, therefore
supporting a role of NMU in regulating adiposity related traits.
Our approach was to use SNPs to tag a number of haplotypes potentially responsible for the
effect, given the expected haplotype structure among Caucasians and the previous association
observed between NMU haplotypes and bone stiffness in the same sample [13]. The absence of
significant associations for the other three haplotypes confirms the utility of the haplotype
approach with respect to the conventional analysis using single, intronic SNPs. This result sug-
gests that the functional variant(s) responsible for the phenotypic variation is in linkage dis-
equilibrium with the CCT haplotype, located in the same haplotype block or in contiguous
blocks. The identification of such haplotype will allow the search for functional variant(s)
through a whole-gene sequencing approach in carriers of the haplotype. In Caucasians, the
CCT haplotype is in strong linkage disequilibrium with a haplotype in the first block of the
gene, as reported in S1 Fig panel c (thick line in the first row). The first two haplotype blocks
cover 9 out 10 exons of NMU and no other genes. Therefore this region includes the entire
NMU-25 peptide and also the proNMU104–136, a longer form derived from the NMU gene
which has shown activity similar to the shorter biologically active peptide in mice [26], as well
as the cleavage region. The identification of functional variants responsible for the observed
effect will be helpful in both risk assessment and treatment of metabolic diseases. Point-muta-
tion studies demonstrated in fact that changes in amino acid sequence may alter binding of
NMU to its receptors, NMUR1 and NMUR2, and may reduce or increase its half-life [27].
In GWAs, SNPs in several genes were associated with BMI, including a number of central
nervous system genes as NMU. However they explained a very low portion of the phenotypic
variance [11]. Given the strong effect as well as the high frequency of the CCT haplotype in the
population (carriers 40%), NMU variants have instead a strong impact on BMI in children.
Since higher BMI in early life increases the adult obesity risk [28], NMU variants could have a
strong effect also in adults, for whom a drug mimicking the effect of NMU carrying the vari-
ants responsible for the effect could have a consistent impact on obesity reduction.
Among boys, no different effect was evident across ages. An influence of age in the associa-
tion between CCT haplotype and BMI was instead evident in girls. Indeed, in girls the associa-
tion between CCT and BMI appeared to be null during the adiposity rebound period and
became evident starting from 7 years. In our previous analyses [13], we observed an age-
dependent association in girls in the association between bone stiffness and NMU, that was
most pronounced below 6 years of age. These trends could be due to age-specific expression of
NMURs as well as NMU in different tissues, which was observed to vary during ageing and to
be regulated by hormones such as ovarian steroids [15,29,30].
We investigated the different components of adiposity using biological impedance mea-
surements and found that the NMU CCT haplotype is associated with a low fat mass. How-
ever, an association with fat-free mass is also suggested by our data, since both fat-free mass
(non-significant) and arm and hip circumferences were lower in the presence of CCT
haplotype. This result is in line with the previously observed negative association with bone
stiffness [13] and with mouse model results [3]. The negative association with arm circum-
ferences suggests an effect also on muscle mass, according to previous evidence of NMU on
physical activity [1]. The reduction in fat mass as well as in hip and arm circumferences
could be then explained by the following activities ascribed to NMU: decreased energy
intake, through appetite regulation; improved metabolism, through insulin sensitivity modu-
lation; increased energy expenditure, through modulation of gross-locomotor activity and
heat production; decreased growth and/or activity of adipocytes, osteoblasts and myocytes
[1]. The complex interplay among these mechanisms could be responsible also for the
observed effect on overweight rather than in obesity. Further analyses on different
NMU haplotypes and adiposity in children
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phenotypes potentially involved could help to elucidate the intermediate factors responsible
for the NMU-mediated effect on anthropometric measures.
The strength of this study was the possibility to evaluate in humans the effect of NMU,
which is difficult to detect in plasma or serum [31]. Moreover, phenotypes in children are
more heritable than those in adults, since the environment has had less time to exert its effect,
therefore they represent a good model for genetic studies. Finally, the large sample size, the
large number of standardized phenotypic measurements, and the availability of T1 data to
check the main results in a second time point strengthen the reliability of the study. As a limi-
tation, the sample size was not powered enough to confirm an association of CCT haplotype
with waist circumference. However, this association was suggested by the significant results
obtained in sensitivity analyses using dominant model or using all merged haplotypes as refer-
ence. Finally, we acknowledge that our tag SNP selection strategy covered only the haplotypes
at frequency higher than 10%. However, this lead to miss the discrimination of only two haplo-
types at low frequency, included in the most prevalent haplotype.
In conclusion, our data support an age- and sex-specific role of NMU in adiposity regula-
tion in children. The effect was mainly driven by peripheral fat mass, although an association
with indicators of bone and muscle mass was evident as well. Sequencing this short haplotypic
block in carriers of CCT haplotype will allow to identify the specific DNA loci involved, useful
for obesity risk assessment and, if located in the exons, for the development of new NMU ana-
logs and inhibitors.
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S1 Fig. NMU gene, linkage disequilibrium plot and haplotype structure. Gene coordinates:
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